(Q51308164)

English

The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study.

scientific article published on 9 February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/25662759

The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study. (English)

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/25662759

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

I Haj-Husein

1

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/25662759

S Tukan

2

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/25662759

F Alkazaleh

3

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/25662759

publication date

9 February 2015

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/25662759

Journal of Human Nutrition and Dietetics

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/25662759

29

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/25662759

1

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/25662759

105-111

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/25662759

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Genomic variants in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Insulin and hyperandrogenism in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Phenolic and triterpenoid antioxidants from Origanum majorana L. herb and extracts obtained with different solvents

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Effects of marjoram volatile oil and grape seed extract on ethanol toxicity in male rats.

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Glucose Intolerance, Insulin Resistance, and Hyperandrogenemia in First Degree Relatives of Women with Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Assessment of insulin resistance in young women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes

1 reference

https://api.crossref.org/works/10.1111%2FJHN.12290

21 January 2018

Identifiers

10.1111/JHN.12290

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/25662759

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/25662759

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51308164&oldid=1588368676"